全文获取类型
收费全文 | 12246篇 |
免费 | 962篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 284篇 |
妇产科学 | 198篇 |
基础医学 | 1544篇 |
口腔科学 | 221篇 |
临床医学 | 1620篇 |
内科学 | 2358篇 |
皮肤病学 | 160篇 |
神经病学 | 1259篇 |
特种医学 | 424篇 |
外国民族医学 | 1篇 |
外科学 | 2004篇 |
综合类 | 198篇 |
现状与发展 | 1篇 |
一般理论 | 9篇 |
预防医学 | 1014篇 |
眼科学 | 224篇 |
药学 | 918篇 |
中国医学 | 47篇 |
肿瘤学 | 710篇 |
出版年
2023年 | 58篇 |
2022年 | 106篇 |
2021年 | 223篇 |
2020年 | 130篇 |
2019年 | 203篇 |
2018年 | 271篇 |
2017年 | 193篇 |
2016年 | 201篇 |
2015年 | 220篇 |
2014年 | 379篇 |
2013年 | 465篇 |
2012年 | 740篇 |
2011年 | 895篇 |
2010年 | 416篇 |
2009年 | 418篇 |
2008年 | 664篇 |
2007年 | 789篇 |
2006年 | 644篇 |
2005年 | 733篇 |
2004年 | 617篇 |
2003年 | 602篇 |
2002年 | 595篇 |
2001年 | 234篇 |
2000年 | 263篇 |
1999年 | 251篇 |
1998年 | 159篇 |
1997年 | 127篇 |
1996年 | 127篇 |
1995年 | 105篇 |
1994年 | 93篇 |
1993年 | 100篇 |
1992年 | 156篇 |
1991年 | 131篇 |
1990年 | 136篇 |
1989年 | 128篇 |
1988年 | 125篇 |
1987年 | 128篇 |
1986年 | 105篇 |
1985年 | 143篇 |
1984年 | 117篇 |
1983年 | 88篇 |
1982年 | 77篇 |
1981年 | 84篇 |
1980年 | 70篇 |
1979年 | 80篇 |
1978年 | 66篇 |
1977年 | 66篇 |
1976年 | 57篇 |
1974年 | 46篇 |
1972年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
Michael J. Zobel Donna Nowicki Gabriel Gomez Jessica Lee Lori Howell Joseph Miller Chadi Zeinati Dean M. Anselmo 《Journal of pediatric surgery》2021,56(5):1062-1067
Background/PurposeCervicofacial lymphatic malformations (CFLM) are rare, potentially life-threatening vascular anomalies, yet reports on multidisciplinary treatment strategies are lacking. We evaluated outcomes for CFLMs following sclerotherapy, surgical resection, and/or medical management.MethodsWe identified children with a CFLM at a vascular anomalies center from 2004 to 2019. Exclusion criteria: retro-orbital malformations, untreated malformations, patients without follow-up. Primary clinical outcome was contour improvement, with significance defined as LM volume reduction of > 50% by cross-sectional imaging.ResultsSixty-three children met inclusion criteria: 35 with macrocystic CFLMs, six with microcystic CFLMs, and 22 with mixed-type malformations. Mean post-intervention follow-up was 27.5 months. Fifty-eight patients underwent sclerotherapy (median: two treatments). Doxycycline and/or bleomycin were used in 95% of patients. After sclerotherapy, 97% of macrocystic CFLMs improved significantly compared to 82% of mixed and 67% of microcystic lesions. Sixteen children underwent surgical resection with 75% significantly improving; two additional patients were successfully treated with sclerotherapy after debulking surgery. Six children received sirolimus for microcystic disease, of which 33% significantly improved.ConclusionSclerotherapy is very effective for macrocystic components of CFLMs, albeit less so for microcystic disease. Microcystic CFLMs frequently require surgical resection. Sirolimus is a helpful therapeutic adjunct, particularly for microcystic lesions, but more study is needed.Level of EvidenceLevel II, prognosis study 相似文献
103.
Jian Zhang Qingyuan Liang Dean Qin Jiefu Song Qijun An Xiaojian Wang Zhongtao Zhao 《The journal of spinal cord medicine》2021,44(3):340
Study Design: Systematic review and meta-analysis.Objective: To compare the effectiveness and safety between anterior and posterior approach, and determine the best surgical methods for the treatment of ossification of the posterior longitudinal ligament (OPLL) in the cervical spine.Methods: We searched the Cochrane Library, PubMed, CNKI and Wanfang Med Data databases from January 2007 to March 2018. Japanese Orthopaedic Association (JOA) scores, cervical lordosis, functional recovery rates, excellent and good outcomes of the surgical approaches, and complication and reoperation rates were analyzed. RevMan 5.3 was utilized for data analysis.Results: Eleven studies were included in the meta-analysis. By comparing the anterior and posterior approaches for the treatment of OPLL in the cervical spine, statistically significant differences were found in the preoperative initial JOA, the postoperative final JOA scores, functional recovery rates, complication rates, excellent and good outcomes of the surgical approaches and reoperation rates. However, no statistically significant difference in the occurrence of the preoperative and postoperative cervical lordosis was noted.Conclusion: The anterior approach is superior to the posterior approach in terms of the postoperative final JOA score, functional recovery rate, and clinical outcomes. Although the complication and reoperation rates of the anterior approach are higher than those of the posterior approach. We recommend the anterior approach for the treatment of OPLL when patients with occupying ratio ≥ 60%. In addition, high-quality studies with long-term follow-up and large sample size are also needed. 相似文献
104.
Dean W. Smith 《Hand (New York, N.Y.)》2021,16(1):NP1
Background: An unusual case involving a middle-aged male with a 9-year history of presumptive chronic regional pain syndrome (CRPS) and ulnar neuropathy was referred for failure in treatment. Methods: On presentation, the patient was requesting an amputation of his arm. However, work-up uncovered a periosteal extra-digital glomus tumor on the base of the small finger metacarpal. Results: Surgical excision of the lesion resulted in rapid resolution of his pain and normal hand function was ultimately restored. Conclusions: Glomus tumors account for up to 5% of all soft tissue tumors of the upper extremity, occurring most frequently within or adjacent to the nail bed. Time from onset of symptoms to correct diagnosis may not be established for many years, especially with atypical tumor locations. Although glomus tumors have been widely reported, atypical locations of these tumors should be included in the differential diagnosis for patients with unusual chronic pain or neuropathy. Furthermore, when evaluating a chronic pain patient, our findings support the opinion that assignment of the diagnosis of CRPS should only be a diagnosis of exclusion. 相似文献
105.
Dean Schillinger Renu Balyan Scott A. Crossley Danielle S. McNamara Jennifer Y. Liu Andrew J. Karter 《Health services research》2021,56(1):132-144
ObjectiveTo develop novel, scalable, and valid literacy profiles for identifying limited health literacy patients by harnessing natural language processing.Data SourceWith respect to the linguistic content, we analyzed 283 216 secure messages sent by 6941 diabetes patients to physicians within an integrated system''s electronic portal. Sociodemographic, clinical, and utilization data were obtained via questionnaire and electronic health records.Study DesignRetrospective study used natural language processing and machine learning to generate five unique “Literacy Profiles” by employing various sets of linguistic indices: Flesch‐Kincaid (LP_FK); basic indices of writing complexity, including lexical diversity (LP_LD) and writing quality (LP_WQ); and advanced indices related to syntactic complexity, lexical sophistication, and diversity, modeled from self‐reported (LP_SR), and expert‐rated (LP_Exp) health literacy. We first determined the performance of each literacy profile relative to self‐reported and expert‐rated health literacy to discriminate between high and low health literacy and then assessed Literacy Profiles’ relationships with known correlates of health literacy, such as patient sociodemographics and a range of health‐related outcomes, including ratings of physician communication, medication adherence, diabetes control, comorbidities, and utilization.Principal FindingsLP_SR and LP_Exp performed best in discriminating between high and low self‐reported (C‐statistics: 0.86 and 0.58, respectively) and expert‐rated health literacy (C‐statistics: 0.71 and 0.87, respectively) and were significantly associated with educational attainment, race/ethnicity, Consumer Assessment of Provider and Systems (CAHPS) scores, adherence, glycemia, comorbidities, and emergency department visits.ConclusionsSince health literacy is a potentially remediable explanatory factor in health care disparities, the development of automated health literacy indicators represents a significant accomplishment with broad clinical and population health applications. Health systems could apply literacy profiles to efficiently determine whether quality of care and outcomes vary by patient health literacy; identify at‐risk populations for targeting tailored health communications and self‐management support interventions; and inform clinicians to promote improvements in individual‐level care. 相似文献
106.
Active-specific immunotherapy for melanoma 总被引:1,自引:0,他引:1
M S Mitchell W Harel R A Kempf E Hu J Kan-Mitchell W D Boswell G Dean L Stevenson 《Journal of clinical oncology》1990,8(5):856-869
Twenty-five patients with metastatic melanoma were treated with a therapeutic vaccine ("theraccine") consisting of allogeneic melanoma lysates and a novel adjuvant, DETOX (Ribi ImmunoChem Research, Inc, Hamilton, MT). Each patient received 200 antigenic units (20 x 10(6) tumor cell equivalents) subcutaneously on weeks 1, 2, 3, 4, and 6. Clinical responses included one complete remission, three partial remissions, and a long-term (17-month) stability. Two other patients had mixed responses, with partial remissions of numerous subcutaneous nodules. Sites of responsive disease included primarily the skin, but ileal, breast, and a liver metastasis also responded. Removal of residual lesions in patients with partial remissions, whose other lesions had disappeared during treatment, led to long disease-free survivals. The median duration of remission was 17 months, with four of the five responders alive for at least 24 months after treatment. An increase in precursors of cytolytic T cells (CTLs) correlated with clinical outcome, when complete, partial, and mixed responses and long-term stability were considered. The CTLs recognized melanoma-associated antigens on many cell lines, but not other types of tumor or normal lymphocytes. Skin-test reactivity to melanoma antigens and serum antibodies against the melanoma cells was unrelated to clinical response. Toxicity was minimal, restricted largely to minor soreness at the site of injection. Only five patients, four of whom were treated with repeated courses, developed severe granulomas. These results confirm that active-specific immunization with allogeneic lysates of melanoma administered with the adjuvant DETOX can induce immunity to melanoma, and can induce regressions of disease in a proportion of patients with metastatic disease with little toxicity. 相似文献
107.
Kenneth V. Honn Dean G. Tang Xiang Gao Igor A. Butovich Bin Liu Jozsef Timar Wolfgang Hagmann 《Cancer metastasis reviews》1994,13(3-4):365-396
Arachidonic acid metabolites have been implicated in multiple steps of carcinogenesis. Their role in tumor cell metastasis, the ultimate challenge for the treatment of cancer patients, are however not well-documented. Arachidonic acid is primarily metabolized through three pathways, i.e., cyclooxygenase, lipoxygenase, and P450-dependent monooxygenase. In this review we focus our attention on one specific lipoxygenase, i.e., 12-lipoxygenase, and its potential role in modulating the metastatic process. In mammalian cells there exist three types of 12-lipoxygenases which differ in tissue distribution, preferential substrates, and profile of their metabolites. Most of these 12-lipoxygenases have been cloned and sequenced, and the molecular and biochemical determinants responsible for catalysis of specific substrates characterized. Solid tumor cells express 12-lipoxygenase mRNA, possess 12-lipoxygenase protein, and biosynthesize 12(S)-HETE [12(S)-hydroxyeicosatetraenoic acid], as revealed by numerous experimental approaches. The ability of tumor cells to generate 12(S)-HETE is positively correlated to their metastatic potential. A large collection of experimental data suggest that 12(S)-HETE is a crucial intracellular signaling molecule that activates protein kinase C and mediates the biological functions of many growth factors and cytokines such as bFGF, PDGF, EGF, and AMF. 12(S)-HETE plays a pivotal role in multiple steps of the metastatic cascade encompassing tumor cell-vasculature interactions, tumor cell motility, proteolysis, invasion, and angiogenesis. The fact that 12-lipoxygenase is expressed in a wide diversity of tumor cell lines and 12(S)-HETE is a key modulatory molecule in metastasis provides the rationale for targeting these molecules in anti-cancer and anti-metastasis therapeutic protocols. 相似文献
108.
109.
Junkins EP Knight S Lightfoot AC Cazier CF Dean JM Corneli HM 《The Journal of school health》1999,69(10):409-412
110.